Abstract
Background
Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a subtype of CAA with an inflammatory response to the vascular β-amyloid deposits. Reliable and non-invasive clinical diagnostic methods may allow patients to avoid the side effects of brain biopsy.
Objective
In this observational study, we retrospectively analyzed the clinical, laboratory, radiological features, treatment, and outcome of patients diagnosed with CAA-ri. The main purpose is to enhance knowledge of CAA-ri and to avoid misdiagnosis.
Methods
We described 15 consecutive patients with probable or possible CAA-ri at Henan Provincial People’s Hospital according to a validation study of proposed criteria for the diagnosis of CAA-ri. The clinical features, imaging, laboratory findings, and treatment which included the response to immunotherapy were revealed in the study.
Results
The median age of 15 patients was 67.0 years (range 48.0–90.0 years), and the male-to-female ratio was 7: 8. In our study, the most common clinical manifestations were cognitive decline (7/15, 46.7%), focal neurologic deficit (6/15, 40.0%), and headache (5/15, 33.3%). In terms of imaging results, white matter hyperintensity (WMH) lesions were rarely seen in the cerebellum and brainstem, while no hemorrhagic lesion was observed in the brainstem of all 15 patients. In addition, 12 patients (80.0%) showed improvement or stability for the clinical and radiological outcomes after immunotherapy.
Conclusion
CAA-ri should be considered as a differential diagnosis when brain MRI shows typical features in the elderly. Once the diagnosis is established, immunotherapy should be initiated as early as possible to promote neurological function recovery and reduce recurrence.
Similar content being viewed by others
References
Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18:311–324
Chung KK, Anderson NE, Hutchinson D, Synek B, Barber PA (2011) Cerebral amyloid angiopathy related inflammation: three case reports and a review. J Neurol Neurosurg Psychiatry 82:20–26
Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ (2020) Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol 16:30–42
Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S (2005) Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128:500–515
Love S (2004) Contribution of cerebral amyloid angiopathy to Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75:1–4
Eng JA, Frosch MP, Choi K, Rebeck GW, Greenberg SM (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 55:250–256
Kirshner HS, Bradshaw M (2015) The Inflammatory Form of Cerebral Amyloid Angiopathy or “Cerebral Amyloid Angiopathy-Related Inflammation” (CAARI). Curr Neurol Neurosci Rep 15:54
Regenhardt RW, Thon JM, Das AS, Thon OR, Charidimou A, Viswanathan A, Gurol ME, Chwalisz BK, Frosch MP, Cho TA, Greenberg SM (2020) Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy-Related Inflammation. JAMA Neurol 77:1261–1269
Auriel E, Charidimou A, Gurol ME, Ni J, Van Etten ES, Martinez-Ramirez S, Boulouis G, Piazza F, DiFrancesco JC, Frosch MP, Pontes-Neto OV, Shoamanesh A, Reijmer Y, Vashkevich A, Ayres AM, Schwab KM, Viswanathan A, Greenberg SM (2016) Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation. JAMA Neurol 73:197–202
Broderick JP, Adeoye O, Elm J (2017) Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke 48:2007–2012
Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43:1683–1689
Greenberg SM, Nandigam RN, Delgado P, Betensky RA, Rosand J, Viswanathan A, Frosch MP, Smith EE (2009) Microbleeds versus macrobleeds: evidence for distinct entities. Stroke 40:2382–2386
Reid AH, Maloney AF (1974) Giant cell arteritis and arteriolitis associated with amyloid angiopathy in an elderly mongol. Acta Neuropathol 27:131–137
Piazza F, Greenberg SM, Savoiardo M, Gardinetti M, Chiapparini L, Raicher I, Nitrini R, Sakaguchi H, Brioschi M, Billo G, Colombo A, Lanzani F, Piscosquito G, Carriero MR, Giaccone G, Tagliavini F, Ferrarese C, DiFrancesco JC (2013) Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol 73:449–458
DiFrancesco JC, Brioschi M, Brighina L, Ruffmann C, Saracchi E, Costantino G, Galimberti G, Conti E, Curtò NA, Marzorati L, Remida P, Tagliavini F, Savoiardo M, Ferrarese C (2011) Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report. Neurology 76:842–844
Fountain NB, Eberhard DA (1996) Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature. Neurology 46:190–197
Ronsin S, Deiana G, Geraldo AF et al (2016) Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation. Neurology 86:912–919
Castro Caldas A, Silva C, Albuquerque L, Pimentel J, Silva V, Ferro JM (2015) Cerebral Amyloid Angiopathy Associated with Inflammation: Report of 3 Cases and Systematic Review. J Stroke Cerebrovasc Dis 24:2039–2048
Raghavan P, Looby S, Bourne TD, Wintermark M (2016) Cerebral amyloid angiopathy-related inflammation: A potentially reversible cause of dementia with characteristic imaging findings. J Neuroradiol 43:11–17
Kinnecom C, Lev MH, Wendell L et al (2007) Course of cerebral amyloid angiopathy-related inflammation. Neurology 68:1411–1416
Bouthour W, Sveikata L, Vargas MI, Lobrinus JA, Carrera E (2018) Clinical Reasoning: Rapid progression of reversible cognitive impairment in an 80-year-old man. Neurology 91:1109–1113
Du Y, Liu C, Ma C et al (2019) Cerebral amyloid angiopathy-related inflammation: a case report presenting with a rare variant in SORL1 gene. BMC Neurol 19:97
Schmechel DE, Saunders AM, Strittmatter WJ et al (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90:9649–9653
Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT (1995) Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38:254–259
Holtzman DM, Bales KR, Tenkova T et al (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A 97:2892–2897
Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN (1996) Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease. Am J Pathol 148:2083–2095
Xu YY, Chen S, Zhao JH, Chen XL, Zhang JW (2019) A Case of Cerebral Amyloid Angiopathy-Related Inflammation With the Rare Apolipoprotein ε2/ε2 Genotype. Front Neurol 10:547
Antolini L, DiFrancesco JC, Zedde M, Basso G, Arighi A, Shima A, Cagnin A, Caulo M, Carare RO, Charidimou A, Cirillo M, Di Lazzaro V, Ferrarese C, Giossi A, Inzitari D, Marcon M, Marconi R, Ihara M, Nitrini R, Orlandi B, Padovani A, Pascarella R, Perini F, Perini G, Sessa M, Scarpini E, Tagliavini F, Valenti R, Vázquez-Costa JF, Villarejo-Galende A, Hagiwara Y, Ziliotto N, Piazza F (2021) Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Prospective Longitudinal Cohort Study. Neurology 97:e1809–e1822
Danve A, Grafe M, Deodhar A (2014) Amyloid beta-related angiitis–a case report and comprehensive review of literature of 94 cases. Semin Arthritis Rheum 44:86–92
DiFrancesco JC, Touat M, Caulo M et al (2015) Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network. J Alzheimers Dis 46:1071–1077
Aghetti A, Sène D, Polivka M et al (2019) Cerebral Amyloid Angiopathy Related Inflammation With Prominent Meningeal Involvement A Report of 2 Cases. Front Neurol 10:984
Silek H, Erbas B (2020) Cerebral Amyloid Angiopathy Related Inflammation Presenting as Steroid Responsive Brain Mass. Turk Neurosurg 30:629–631
Carlo S, Morris Jonathan M, Caterina G, Brown Robert D, Teresa C, Hunder Gene G (2016) Imaging findings of cerebral amyloid angiopathy, Aβ-related angiitis (ABRA), and cerebral amyloid angiopathy-related inflammation: a single-institution 25-year experience. Medicine 95:e3613
Tetsuka S, Hashimoto R (2019) Slightly Symptomatic Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Remission in Four Months. Case Rep Neurol Med 2019:5308208
Taniguchi Y, Kitamura T, Inoue H, Miura T, Yamada K (2019) Amyloid β related angitis without marked leukoencephalopathy. Rinsho Shinkeigaku 59:814–817
Masrori P, Montagna M, De Smet E, Loos C (2019) Posterior reversible encephalopathy syndrome caused by cerebral amyloid angiopathy-related inflammation. Acta Neurol Belg 119:505–507
Funding
This work was supported by grant from the National Natural Science Foundation of 643 China (No. 81873727).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the local Institutional Review Board and all written informed consent was obtained from all patients included.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, D., Qin, W., Guo, Y. et al. Clinical, laboratory, and radiological features of cerebral amyloid angiopathy-related inflammation (CAA-ri): retrospective, observational experience of a single centre. Neurol Sci 44, 631–638 (2023). https://doi.org/10.1007/s10072-022-06436-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06436-7